K-MELLODY Project Group: Accelerating New Drug Development with Collective Learning-Based Approach
Pharmaceutical and Biotechnology Association opens K-MELLODY business unit Resolve data distribution issues and maximize research efficiency Choose detailed business in June, start first year project in July On the 17th, the Korea Pharmaceutical and Biotechnology Society held an opening ceremony for the ‘Collective Learning-Based New Drug Development Acceleration Project Team’ (K-MELLODY Project Group) at the […]
Korea Pharmaceutical and Biotechnology Association Launches Collective Learning-Based New Drug Development Project
On the 17th, the Korea Pharmaceutical and Biotechnology Association held an opening ceremony for the Association’s ‘Collective Learning-Based New Drug Development Acceleration Project Group (K-MELLODDY Project Group)’. The Korea Pharmaceutical and Biotechnology Society (Chairman Noh Yeon-hong) announced on the 17th that it is holding an opening ceremony for the ‘Learning-Based New Drug Development Acceleration Project […]
Former Lotte Giants Players Given Suspended Sentences in False Evidence Trial: Busan District Court
Busan District Court./Chosun Ilbo DB Former professional baseball players Kim Sa-yul (44) and Song Seung-jun (44) of the Lotte Giants, who were on trial on charges of giving false evidence regarding the purchase of banned substances, were given suspended prison sentences in the appeals. court. The Criminal Appeals Division of the Busan District Court 3-2 […]
Dong-A ST Unveils Preclinical Results of SHP1 Allosteric Inhibitor and Immunotherapy Drug ‘DA-4511’ at the AACR
Dong-A ST announces preclinical results of the SHP1 allosteric inhibitor and immunotherapy drug ‘DA-4511’ at the AACR. Dong-A ST (CEO and President Kim Min-young) will present SHP1 allosteric inhibitor and immunotherapy drug ‘DA-4511’ at the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, California, USA from the 5th to the 10th. It […]
HK InnoN Celebrates 40th Anniversary with Founding Ceremony and Commitment to Compliance
HK inno.N announced on the 1st that it is holding a founding ceremony at its headquarters in Osong, Chungcheongbuk-do (located in Cheongju-si, Chungcheongbuk-do) on the 29th of last month to commemorate its 40th -year To celebrate its 40th anniversary, HK Innoen held a founding ceremony at its headquarters in Osong, Chungcheongbuk-do (located in Cheongju-si, Chungcheongbuk-do) […]
Big S and Ex-Husband Wang Xiaofei’s Long-Distance Battle: Accusations of Domestic Violence and Drug Abuse
Recently, the artist Big S (Xu Xiyuan) and her ex-husband Wang Xiaofei started fighting again from afar. (Photo / newspaper photo) The artist Big S (Xu Xiyuan) and her ex-husband Wang Xiaofei started a long-distance fight again. Both sides accused each other of domestic violence, cheating, etc., causing quite a stir. Yesterday (22nd), it was […]
Hanmi Pharmaceutical to Unveil 10 New Research Projects at AACR 2024
Hanmi Science (hereinafter referred to as Hanmi Group), a core business company, Hanmi Pharmaceutical, will participate in the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, USA from April 5 to 10 and reveals 10 new research projects, the largest number in the industry It was announced on the 18th that it […]
Hanmi Pharmaceutical Set to Unveil 10 New Research Projects at AACR 2024
Hanmi Science (hereinafter referred to as Hanmi Group), a core business company, Hanmi Pharmaceutical, will participate in the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, USA from April 5 to 10 and reveals 10 new research projects, the largest number in the industry It was announced on the 18th that it […]
The Future of OCI and South Korean Relations with OCI
í•œë¯¸ì•½í’œê·¸ë£¹ì ˜ OCI 통합과 ê´€ë ¨í•œ 오너 ì ¼ê°€ì ˜ ê°ˆë“±ì ´ ì°¨ ì‹¬í™”ë ˜ëŠ” ì–’ìƒ ì ´ë‹¤. 한미약품그룹과 OCI 그룹간 í†µí•©ì „ 막기 위한 ì‚¬ì „ ì¡° ì¹˜ì ¸ ì‹ ì£¼ë°œí–‰ê¸ˆì§€ 가처분 ì‹ ì²ì— 대해 ì†í–‰ì ´ ê²°ì •ë 다 . ì ´ì— ëŒ€í•´ í†µí•©ì „ ë’ ê³ íŒ½íŒ½ížˆ ë§žì„œê³ ìžˆëŠ” 오너 ì ¼ê°€ëŠì„ […]
Daewoong Pharmaceutical’s Versiporosin Approved as World’s First Orphan Drug for Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical (CEO Seung-ho Jeon and Chang-jae Lee) has approved ‘Versiporosin (DWN12088),’ an idiopathic pulmonary fibrosis candidate in development as a world first new drug (first in class), as an orphan drug by the European Medicines Agency (EMA) It was announced on the 29th that it was additionally designated as. According to the company, versiporosin […]
